In this study, we comprehensively evaluated the immune-inflammatory axis, comprising PD-L1 (CD274), COX-2 (PTGS2), 15-PGDH (HPGD), and TILs across multiple CRC cohorts and platforms. This evidence concerns the gene PTGS2 and colorectal carcinoma.